[250 Pages Report] The global omega-3 concentrates market size is projected to exhibit growth at a considerable CAGR of 7.5% and reach US$ 5.3 Billion in the forecast period from 2022 to 2032. It is expected to be valued at US$ 2.4 Billion in 2022. The high spending by consumers in both developed and developing economies on healthy foods and dietary supplements is anticipated to drive the demand for omega-3 concentrates in future.
| Report Attribute | Details |
|---|---|
| Omega-3 Concentrates Market Estimated Base Year Value (2021) | US$ 1.7 Billion |
| Omega-3 Concentrates Market Expected Market Value (2022) | US$ 2.4 Billion |
| Omega-3 Concentrates Market Anticipated Forecast Value (2032) | US$ 5.3 Billion |
| Omega-3 Concentrates Market Projected Growth Rate (2022 to 2032) | 7.5% CAGR |
Omega-3 concentrates are highly concentrated oils that contain DHA and EPA which sum up more than 50%. These are mainly obtained from omega-3 rich oils, which are processed by technologically advanced facilities to gain a higher concentration of DHA or EPA.
These are easily available in the powder and oil form and are extensively used by manufacturers of dietary supplements to produce capsules. At the same time, these are utilized as a pharmaceutical grade component, as well as in food and beverages.
The emergence of new entrants in the market is another crucial factor that is likely to drive the growth. In March 2022, for instance, Else Nutrition Holdings Inc. unveiled its latest nutrition drink named Else Toddler Omega. It is the company’s first-ever toddler product that is equipped with Omega 3 fatty acids for eye and brain development. The launch of similar other innovative products is anticipated to accelerate the growth in this market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing awareness about various attributes and health benefits provided by omega-3 concentrates is projected to drive the market. The rising spending by consumers on healthy products owing to improving lifestyles and high disposable income is another major factor that is anticipated to propel the sales of omega-3 concentrates in the near future.
The growing focus of renowned suppliers and manufacturers on the expansion of their supply chain, especially in emerging economies is likely to bode well for the market. The ongoing development of various state-of-the-art products, such as non-GMO and gluten-free concentrates is estimated to fuel the growth in this market.
The high cost of omega-3 concentrates may hamper the growth in this market. The expensive nature of such products would make it difficult for people in developing companies to afford these. However, the entry of a large number of key players in the market is expected to result in the reduced prices of these concentrates, which may propel the market.
Principal Consultant
Asia Pacific is projected to remain at the forefront by accounting for the largest omega-3 concentrates market share in the evaluation period. This growth is attributable to the rapid inclination of consumers towards a healthy diet infused with omega-3 ingredients in India and China.
China is considered to be the third-largest market for DHA and EPA oils across the globe. The surging usage of fish oil in this country, as well as the high demand for novel dietary supplements would propel the market in China.
In addition to this, the increasing demand for algal DHA oil in the fortified food and beverage industry is estimated to augur well for the regional market. In India, the higher usage of fortified omega-3 products, such as health drinks, eggs, and cooking oil is set to spur the growth.
The rising awareness about cutting-edge concentrates, especially algal oils for fighting depression, as well as enhancing cardiovascular and joint health in Australia is also likely to bolster the growth.
The presence of several renowned companies in the U.S. and Canada is anticipated to augur well for the omega-3 concentrates market growth across North America. As per FMI, the demand for ultra-high omega-3 concentrates is expected to grow in the assessment period owing to the increasing cases of omega-3 deficiency in North America.
Various companies based in this region are set to consistently launch unique products to cater to the ever-increasing demand from the populace. In March 2022, for instance, Neptune Wellness Solutions Inc., a health and wellness company based in Canada, introduced its new range of supplements called Forest Remedies Multi Omega 3-6-9 across the U.S.
These are made with Ahiflower oil and this launch would help the company to strengthen its position in the consumer packaged goods sector. Thus, the increasing number of new product launches are likely to boost the market in North America.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global omega-3 concentrates market consists of some of the leading key players, including Australian Omega Oils Pty. Ltd., BASF SE, Epax Norway, K Pharmtech Co., Ltd., GC Rieber VivoMega, AlaskOmega Golden Omega S.A., Norwegian Fish Oil, Nordic Naturals, Inc., and DSM Nutritional Products AG among others.
The global market is highly fragmented with the presence of many large- and small-scale companies. Majority of these companies are focusing on mergers and acquisitions with local players to expand their geographic presence. A few other players are aiming to engage in collaborations and joint ventures with reputed firms to strengthen their positions and develop innovative products.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.5% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global omega-3 concentrates market is likely to exceed US$ 5.3 Billion by 2032.
Asia Pacific is expected to dominate the omega-3 concentrates market.
Australian Omega Oils Pty. Ltd., BASF SE, Epax Norway, K Pharmtech Co., Ltd., GC Rieber VivoMega, and AlaskOmega Golden Omega S.A. are some of the leading omega-3 concentrates manufacturers.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Omega-3 Concentrates Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (MT) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Alpha-Linolenic Acid (ALA) 5.3.2. Eicosapentaenoic Acid (EPA) 5.3.3. Docosahexaneoic Acid (DHA) 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Concentrate Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Concentrate Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Concentrate Type, 2022-2032 6.3.1. Triglyceride (TG) 6.3.2. Ethyl Ester (EE) 6.3.3. Phospholipids (PL) 6.4. Y-o-Y Growth Trend Analysis By Concentrate Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Concentrate Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Source 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Source, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Source, 2022-2032 7.3.1. Plant 7.3.2. Meat 7.3.3. Eggs 7.3.4. Dairy 7.3.5. Fish 7.3.6. Algae 7.4. Y-o-Y Growth Trend Analysis By Source, 2017-2021 7.5. Absolute $ Opportunity Analysis By Source, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Form 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Form, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Form, 2022-2032 8.3.1. Oil 8.3.2. Powder 8.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021 8.5. Absolute $ Opportunity Analysis By Form, 2022-2032 Deep-dive segmentation will be available in the sample on request 9. Global Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Application, 2017-2021 9.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Application, 2022-2032 9.3.1. Food and Beverage 9.3.2. Pharmaceutical 9.3.3. Nutraceutical/ Dietary Supplements 9.3.4. Infant Formula 9.3.5. Personal Care and Cosmetics 9.3.6. Animal Feed 9.3.7. Pet Food 9.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 9.5. Absolute $ Opportunity Analysis By Application, 2022-2032 Deep-dive segmentation will be available in the sample on request 10. Global Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Region, 2017-2021 10.3. Current Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Region, 2022-2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia & Pacific 10.3.6. MEA 10.4. Market Attractiveness Analysis By Region 11. North America Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. U.S. 11.2.1.2. Canada 11.2.2. By Product Type 11.2.3. By Concentrate Type 11.2.4. By Source 11.2.5. By Form 11.2.6. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Concentrate Type 11.3.4. By Source 11.3.5. By Form 11.3.6. By Application 11.4. Key Takeaways 12. Latin America Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Mexico 12.2.1.2. Brazil 12.2.1.3. Rest of Latin America 12.2.2. By Product Type 12.2.3. By Concentrate Type 12.2.4. By Source 12.2.5. By Form 12.2.6. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Concentrate Type 12.3.4. By Source 12.3.5. By Form 12.3.6. By Application 12.4. Key Takeaways 13. Europe Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. Italy 13.2.1.3. France 13.2.1.4. U.K. 13.2.1.5. Spain 13.2.1.6. BENELUX 13.2.1.7. Russia 13.2.1.8. Rest of Europe 13.2.2. By Product Type 13.2.3. By Concentrate Type 13.2.4. By Source 13.2.5. By Form 13.2.6. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Concentrate Type 13.3.4. By Source 13.3.5. By Form 13.3.6. By Application 13.4. Key Takeaways 14. East Asia Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Concentrate Type 14.2.4. By Source 14.2.5. By Form 14.2.6. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Concentrate Type 14.3.4. By Source 14.3.5. By Form 14.3.6. By Application 14.4. Key Takeaways 15. South Asia & Pacific Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. India 15.2.1.2. ASEAN 15.2.1.3. Australia and New Zealand 15.2.1.4. Rest of South Asia & Pacific 15.2.2. By Product Type 15.2.3. By Concentrate Type 15.2.4. By Source 15.2.5. By Form 15.2.6. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Concentrate Type 15.3.4. By Source 15.3.5. By Form 15.3.6. By Application 15.4. Key Takeaways 16. MEA Omega-3 Concentrates Market Analysis 2017-2021 and Forecast 2022-2032, By Country 16.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021 16.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. Turkey 16.2.1.3. South Africa 16.2.1.4. Rest of MEA 16.2.2. By Product Type 16.2.3. By Concentrate Type 16.2.4. By Source 16.2.5. By Form 16.2.6. By Application 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product Type 16.3.3. By Concentrate Type 16.3.4. By Source 16.3.5. By Form 16.3.6. By Application 16.4. Key Takeaways 17. Key Countries Omega-3 Concentrates Market Analysis 17.1. U.S. 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2021 17.1.2.1. By Product Type 17.1.2.2. By Concentrate Type 17.1.2.3. By Source 17.1.2.4. By Form 17.1.2.5. By Application 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2021 17.2.2.1. By Product Type 17.2.2.2. By Concentrate Type 17.2.2.3. By Source 17.2.2.4. By Form 17.2.2.5. By Application 17.3. Mexico 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2021 17.3.2.1. By Product Type 17.3.2.2. By Concentrate Type 17.3.2.3. By Source 17.3.2.4. By Form 17.3.2.5. By Application 17.4. Brazil 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2021 17.4.2.1. By Product Type 17.4.2.2. By Concentrate Type 17.4.2.3. By Source 17.4.2.4. By Form 17.4.2.5. By Application 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2021 17.5.2.1. By Product Type 17.5.2.2. By Concentrate Type 17.5.2.3. By Source 17.5.2.4. By Form 17.5.2.5. By Application 17.6. Italy 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2021 17.6.2.1. By Product Type 17.6.2.2. By Concentrate Type 17.6.2.3. By Source 17.6.2.4. By Form 17.6.2.5. By Application 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2021 17.7.2.1. By Product Type 17.7.2.2. By Concentrate Type 17.7.2.3. By Source 17.7.2.4. By Form 17.7.2.5. By Application 17.8. U.K. 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2021 17.8.2.1. By Product Type 17.8.2.2. By Concentrate Type 17.8.2.3. By Source 17.8.2.4. By Form 17.8.2.5. By Application 17.9. Spain 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2021 17.9.2.1. By Product Type 17.9.2.2. By Concentrate Type 17.9.2.3. By Source 17.9.2.4. By Form 17.9.2.5. By Application 17.10. BENELUX 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2021 17.10.2.1. By Product Type 17.10.2.2. By Concentrate Type 17.10.2.3. By Source 17.10.2.4. By Form 17.10.2.5. By Application 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2021 17.11.2.1. By Product Type 17.11.2.2. By Concentrate Type 17.11.2.3. By Source 17.11.2.4. By Form 17.11.2.5. By Application 17.12. China 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2021 17.12.2.1. By Product Type 17.12.2.2. By Concentrate Type 17.12.2.3. By Source 17.12.2.4. By Form 17.12.2.5. By Application 17.13. Japan 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2021 17.13.2.1. By Product Type 17.13.2.2. By Concentrate Type 17.13.2.3. By Source 17.13.2.4. By Form 17.13.2.5. By Application 17.14. South Korea 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2021 17.14.2.1. By Product Type 17.14.2.2. By Concentrate Type 17.14.2.3. By Source 17.14.2.4. By Form 17.14.2.5. By Application 17.15. India 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2021 17.15.2.1. By Product Type 17.15.2.2. By Concentrate Type 17.15.2.3. By Source 17.15.2.4. By Form 17.15.2.5. By Application 17.16. ASEAN 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2021 17.16.2.1. By Product Type 17.16.2.2. By Concentrate Type 17.16.2.3. By Source 17.16.2.4. By Form 17.16.2.5. By Application 17.17. Australia and New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2021 17.17.2.1. By Product Type 17.17.2.2. By Concentrate Type 17.17.2.3. By Source 17.17.2.4. By Form 17.17.2.5. By Application 17.18. GCC Countries 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2021 17.18.2.1. By Product Type 17.18.2.2. By Concentrate Type 17.18.2.3. By Source 17.18.2.4. By Form 17.18.2.5. By Application 17.19. Turkey 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2021 17.19.2.1. By Product Type 17.19.2.2. By Concentrate Type 17.19.2.3. By Source 17.19.2.4. By Form 17.19.2.5. By Application 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2021 17.20.2.1. By Product Type 17.20.2.2. By Concentrate Type 17.20.2.3. By Source 17.20.2.4. By Form 17.20.2.5. By Application 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product Type 18.3.3. By Concentrate Type 18.3.4. By Source 18.3.5. By Form 18.3.6. By Application 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Croda International plc 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. NOW Health Group 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Omega Protein Corporation 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Pelagia AS 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. GC Rieber Oils AS 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. Pharma Marine AS 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. Copeinca ASA 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. Arista Industries Inc 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. Clover Corporation 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. KD Pharma 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 19.1.11. Luhua Biomarine (Shandong) Co., Ltd 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.11.5.2. Product Strategy 19.1.11.5.3. Channel Strategy 19.1.12. POLARIS Nutritional Lipids 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.12.5.2. Product Strategy 19.1.12.5.3. Channel Strategy 19.1.13. Algaecytes 19.1.13.1. Overview 19.1.13.2. Product Portfolio 19.1.13.3. Profitability by Market Segments 19.1.13.4. Sales Footprint 19.1.13.5. Strategy Overview 19.1.13.5.1. Marketing Strategy 19.1.13.5.2. Product Strategy 19.1.13.5.3. Channel Strategy 19.1.14. Qualitas Health 19.1.14.1. Overview 19.1.14.2. Product Portfolio 19.1.14.3. Profitability by Market Segments 19.1.14.4. Sales Footprint 19.1.14.5. Strategy Overview 19.1.14.5.1. Marketing Strategy 19.1.14.5.2. Product Strategy 19.1.14.5.3. Channel Strategy 19.1.15. Barleans Organic Oils 19.1.15.1. Overview 19.1.15.2. Product Portfolio 19.1.15.3. Profitability by Market Segments 19.1.15.4. Sales Footprint 19.1.15.5. Strategy Overview 19.1.15.5.1. Marketing Strategy 19.1.15.5.2. Product Strategy 19.1.15.5.3. Channel Strategy 19.1.16. Denomega Nutritional Oils 19.1.16.1. Overview 19.1.16.2. Product Portfolio 19.1.16.3. Profitability by Market Segments 19.1.16.4. Sales Footprint 19.1.16.5. Strategy Overview 19.1.16.5.1. Marketing Strategy 19.1.16.5.2. Product Strategy 19.1.16.5.3. Channel Strategy 19.1.17. Qponics Limited 19.1.17.1. Overview 19.1.17.2. Product Portfolio 19.1.17.3. Profitability by Market Segments 19.1.17.4. Sales Footprint 19.1.17.5. Strategy Overview 19.1.17.5.1. Marketing Strategy 19.1.17.5.2. Product Strategy 19.1.17.5.3. Channel Strategy 19.1.18. Cellana Inc. 19.1.18.1. Overview 19.1.18.2. Product Portfolio 19.1.18.3. Profitability by Market Segments 19.1.18.4. Sales Footprint 19.1.18.5. Strategy Overview 19.1.18.5.1. Marketing Strategy 19.1.18.5.2. Product Strategy 19.1.18.5.3. Channel Strategy 19.1.19. Koninklijke DSM N.V. 19.1.19.1. Overview 19.1.19.2. Product Portfolio 19.1.19.3. Profitability by Market Segments 19.1.19.4. Sales Footprint 19.1.19.5. Strategy Overview 19.1.19.5.1. Marketing Strategy 19.1.19.5.2. Product Strategy 19.1.19.5.3. Channel Strategy 19.1.20. Cargill Incorporated 19.1.20.1. Overview 19.1.20.2. Product Portfolio 19.1.20.3. Profitability by Market Segments 19.1.20.4. Sales Footprint 19.1.20.5. Strategy Overview 19.1.20.5.1. Marketing Strategy 19.1.20.5.2. Product Strategy 19.1.20.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Recommendations
Food and Beverage
April 2019
REP-GB-9477
June 2022
250 pages
Explore Food and Beverage Insights
View Reports
Omega-3 Concentrates Market
